Jiwei Zhang

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Ji-wei Zhang
Publication record
23 papers · 211 citations · H-index 9

PAPERS

A patent review of anti-coronavirus agents targeting the spike-ACE2 interaction (2019–present)
20252 citationsauthor #3
AL5E: A breakthrough in broad-spectrum coronavirus inactivation through structure-guided design
20250 citationsauthor #2
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.
20243 citationsauthor #3
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
202428 citationsauthor #3
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles.
20243 citationsauthor #1
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo.
20244 citationsauthor #2
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties.
20237 citationsauthor #2
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
20232 citationsauthor #1
Unveiling innovative anti-influenza agents through modern medicinal chemistry approaches (2019-2023 updates).
20230 citationsauthor #4
Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2
202313 citationsauthor #7
Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors.
20234 citationsauthor #6
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models
202346 citationsauthor #13
Sulfonic acid: key drug design elements with potent, broad-ranging pharmacological activities.
20234 citationsauthor #3
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity.
202212 citationsauthor #8
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
202210 citationsauthor #2
Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitors.
20226 citationsauthor #7
Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors.
202215 citationsauthor #3
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
202018 citationsauthor #8
Efficient syntheses of π-electron deficient macrocycles
20200 citationsauthor #3
Design and synthesis of chitin synthase inhibitors as potent fungicides
20178 citationsauthor #2
Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin
201523 citationsauthor #3
Synthesis and Bioactivities of Nucleoside Compounds Containing Substituted Benzoyl Carbamate Thiourea
20133 citationsauthor #1
Synthesis and Fungicidal Activities of Nucleoside Compounds Containing Substituted Benzoyl Thiourea
20122 citationsauthor #2

TIMELINE

2012 2 citations

2013 3 citations

2015 23 citations

2017 8 citations

2020 18 citations

2022 43 citations

2023 76 citations

2024 38 citations

2025 2 citations

Jiwei Zhang

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT